Christine’s Newsletter

Share this post

User's avatar
Christine’s Newsletter
Unlike conventional vaccines, nirsevimab — a new RSV shot for infants — is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety data is limited.

Unlike conventional vaccines, nirsevimab — a…

Christine
Sep 4, 2024
4

Share this post

User's avatar
Christine’s Newsletter
Unlike conventional vaccines, nirsevimab — a new RSV shot for infants — is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety data is limited.
1
1

RSV Shots for Babies Lack Long-term Safety Data

Read →
1 Comment
User's avatar
AKcidentalwriter's avatar
AKcidentalwriter
Sep 4

What safety data. That is a joke. It is just right to the market now. Real time is how it goes now. We are just lab rats.

https://theconversation.com/covid-19-flu-and-rsv-shots-an-epidemiologist-explains-why-all-three-matter-this-fall-237443

The article I just saw today. Full steam ahead.

Expand full comment
Reply
Share
© 2025 Christine
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share